Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Pelvic binder and pelvic haemorrhage

Musculoskeletal medicine and orthopaedics · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Unstable pelvis with shock

Pelvic venous plexus, cancellous bone and arterial injury can produce massive retroperitoneal haemorrhage, and repeated manipulation may disrupt early tamponade.

Action: Do not spring the pelvis; apply a purpose-made binder centred over the greater trochanters, activate major-haemorrhage resuscitation, document limb perfusion and application time, and obtain immediate pelvic-trauma, surgical and interventional-radiology input for definitive control.

Synopsis

Recognise pelvic ring injury as a concealed bleeding source, apply and monitor a binder correctly, detect associated urogenital damage, and choose rapid packing, fixation or embolisation pathways.

  • Suspect pelvic bleeding after high-energy blunt trauma with shock, pelvic pain, perineal signs or an unreliable examination; avoid repeated compression or distraction testing.
  • Place a purpose-made binder around the greater trochanters, not the iliac crests or abdomen, pull to the device specification and confirm position clinically and radiographically.
  • A binder is temporary haemorrhage control; continue warmed blood, TXA within 3 hours, calcium and coagulation management and definitive pelvic source-control planning.
  • For a suitable responder, contrast CT defines ring injury and active arterial bleeding; a persistent non-responder needs direct packing, fixation, embolisation or a hybrid route without avoidable scan delay.
  • Do not remove the binder merely for imaging or examination. Removal should occur in a controlled setting with senior pelvic expertise and an agreed stabilisation plan.
  • Inspect perineum and external genitalia once, with dignity and only clinically indicated internal examination; look for wounds, blood and degloving rather than repeatedly manipulating the ring.
  • Blood at the meatus or other urethral signs requires early urological discussion and a urethral-imaging or urinary-diversion plan before repeated catheter attempts.
  • Document binder brand, position, time, skin checks and pre- and post-application distal neurology and perfusion; continue VTE and pressure-area planning after haemostasis.

Key red flags

High-energy mechanism with shock, pelvic or sacral pain, perineal bruising, limb-length change or mechanical instability should be treated as pelvic haemorrhage until assessed and controlled.

Blood at the urethral meatus, inability to void, gross haematuria, scrotal or labial swelling, vaginal or rectal bleeding suggests associated urogenital or open pelvic injury.

Persistent instability despite a correctly positioned binder and blood indicates continued pelvic arterial, venous or non-pelvic bleeding and requires immediate source-control escalation.

Investigation priorities

01
Immediate pelvic radiographFirst step

Identify major ring disruption during unstable resuscitation and check binder level.

02
Preferred contrast CT in a suitable responderPreferred

Define fracture pattern, active bleeding and associated organ injury.

Management branches

ImmediateBind and resuscitate

Pelvic injury is suspected with haemodynamic instability or a high-risk mechanism and unreliable examination.

  1. Apply the binder over the greater trochanters with minimal movement, avoid springing and document distal neurovascular status and application time.
  2. Activate major-haemorrhage support, use warmed blood, give timely tranexamic acid and correct temperature, calcium and clotting deficits.
  3. Inspect for open, perineal and urogenital injury and involve pelvic trauma, general surgery, urology and interventional radiology as findings require.
  4. Reassess response immediately and decide whether CT is safe or direct packing, fixation or embolisation is needed.

Key medicines

Tranexamic acidFor suspected major pelvic bleeding, give 1 g intravenously over 10 minutes followed by 1 g infused over 8 hours, beginning as early as possible and within 3 hours of injury.Do not allow administration to delay packing, fixation or embolisation; routine use after 3 hours is not advised unless hyperfibrinolysis is specifically identified, and renal impairment increases exposure.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG39 Major trauma: assessment and initial management
  • BOASt management of urological trauma associated with pelvic fractures
  • NICE NG37 Fractures complex: assessment and management
  • Cyklokapron 100 mg per mL solution for injection SmPC

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom